ATHE Alterity Therapeutics Limited American Depositary Shares Pharmaceutical Preparations Best Pharmaceutical Stocks 2026 →

Alterity Therapeutics (ATHE) Stock: Buy, Sell, or Hold?

$1.96
-0.14 (-6.44%) β–Ό
5d: -19.34% 30d: -27.94% 90d: -57.11%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (47%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$2.09 – $2.86
Position: OVERSOLD
Forward P/E & Valuation
-2.2x
Next 12M consensus est.
Wall Street Target
$13.25
+576.0% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$1.70 / $3.29
Trend: Strong Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ATHE is down 19.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

Get Alerted When ATHE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ATHE is currently trading at $1.96, which is considered oversold relative to its 30-day fair value range of $2.09 to $2.86.

Technical Outlook: Technically, ATHE is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $3.29. Short-term momentum is weak, with the stock down 6.4% recently.

Market Sentiment: ATHE scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.25 (+576.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $2.09 - $2.86
Company Quality Score 41/100 (HOLD)
Volume Confirmation MODERATE
Confidence Score 47.4%

Trading Range & Key Levels

30-Day Trading Range $2.09 - $2.86
Current vs Trading Range OVERSOLD
Support Level $1.70
Resistance Level $3.29
Current Trend Strong Downtrend
Technical data as of Nov 13, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (33/100)
  • BEARISH: Downward momentum (-6.4%)
  • BULLISH: Trading 576.0% below Wall St target ($13.25)
  • WARNING: Composite score 41/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -2.20
Wall Street Target $13.25 (+576.0%)
Revenue Growth (YoY) -79.0%
Share ATHE Analysis

Share this live ATHE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ATHE)

Bearish 1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Jan 21, 2022
Daily AI digest
AI Retail Discussion Summary: Reddit & WallStreetBets discussions on ATHE are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 6:43 AM ET
Data refreshes hourly during market hours. Next update: 7:43 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ATHE.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$107 69 BUY
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 41 HOLD
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 48 HOLD
IMNM
ImmunomeΒ Inc
STRONG BUY
17 analysts
$35 47 HOLD
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$86 46 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ATHE Research Pages
ATHE Technical Chart ATHE Price Prediction ATHE Intrinsic Value DCF ATHE Earnings Date ATHE Investment Advisor ATHE Fair Price Analyzer ATHE Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals